ProText Mobility, Inc. engages in the development of pharmaceutical applications for botanical drugs. It has license to develop Phytofare, which is a bioavailable extract produced from live green tea leaves that has been clinically proven in double-blind human trials to have ten-times greater bioavailability over generic extract. The company was founded on September 5, 2001 and is headquartered in Miami, FL.